Grace Therapeutics (GRCE) Restructuring Costs (2023)

Grace Therapeutics has disclosed Restructuring Costs across 1 years of filings, most recently posting $1.5 million for Q2 2023.

• In Q2 2023, Restructuring Costs changed N/A year-over-year to $1.5 million; the TTM figure through Mar 2024 stood at $1.5 million (changed N/A YoY), while the FY2024 annual figure was $1.5 million, changed N/A from the prior year.
• Restructuring Costs came in at $1.5 million for Q2 2023 at Grace Therapeutics.
• In the past five years, Restructuring Costs ranged from a high of $1.5 million in Q2 2023 to a low of $1.5 million in Q2 2023.